Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000119·Co-Diagnostics, Inc.
Schedule 13G ownership disclosure
CO-DIAGNOSTICS INC
Common Stock · CUSIP: 189763105
Event date: 2025-09-30
- Filing-level shares
- 1,705,952
- Percent of class
- 3.54%
- The Vanguard Group
Shares: 1,705,952 · Class: 3.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000119
- Form type
- SCHEDULE 13G/A
- Filer
- Co-Diagnostics, Inc.
- CIK
- CIK 1692415
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership